Drug Shortage Report for RENVELA
| Report ID | 71284 |
| Drug Identification Number | 02354586 |
| Brand name | RENVELA |
| Common or Proper name | Renvela |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | Sevelamer Carbonate |
| Strength(s) | 800MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 180 |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2019-01-03 |
| Estimated end date | 2019-01-11 |
| Actual end date | 2019-01-09 |
| Shortage status | Resolved |
| Updated date | 2019-01-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-01-10 | French | Compare |
| v3 | 2019-01-10 | English | Compare |
| v2 | 2019-01-04 | French | Compare |
| v1 | 2019-01-04 | English | Compare |
Showing 1 to 4 of 4